TP027175
Pseudoginsenoside F11;(3b,6a,12b,24R)-20,24-Epoxy-3,12,25-trihydroxydammaran-6-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside;(3b,6a,12b,24R)-20,24-Epoxy-3,12,25-trihydroxydammaran-6-yl 2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside;b-D-Glucopyranoside, (3b,6a,12b,24R)-20,24-epoxy-3,12,25-trihydroxydammaran-6-yl 2-O-(6-deoxy-a-L-mannopyranosyl)-;Ginsenoside A1;PSEUDOGINSENOSIDE F11(P) PrintBack;Pseudoginsenoside F11;(24R)-Pseudoginsenoside F11;(3b,6a,12b,24R)-20,24-Epoxy-3,12,25;24(S)-pseudo-ginsenoside-F11;PSEUDOGINSENOSIDE;Pseudoginsenoside FII;Pseudoginsenoside-F11;pseudo-ginsenoside-Fll;Pseuginsenoside F11;Pseuginsensoside F11;(3β,6α,12β,24R)-20,24-Epoxy-3,12,25-trihydroxydammaran-6-yl 2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside;(2R)-2-[(2S)-2-[[(5R,8R,9S,10R,13S,14R,17R)-3,12-Dihydroxy-17-[(2S)-5-(2-hydroxypropan-2-yl)-2-methy;HMS3327I02;HMS3350F20
C42H72O14
801.01